M.C. de Vernejoul - Concepedia

Author

M.C. de Vernejoul

Also Known As

M C De Vernejoul, M C de Vernejoul, M C. De Vernejoul, M-C de Vernejoul, M. -C. de Vernejoul, M. C. DE VERNEJOUL, M. C. De Vernejoul, M. C. de Vernejoul, M. Christine de Vernejoul, M.-C De Vernejoul

187

Publications

6.8K

Citations

H-Index

123

Concepts

All Affiliations

Inserm Hôpital Lariboisière Université Paris Cité Hôpital Necker-Enfants Malades Hôpital Edouard Herriot

About

M.C. de Vernejoul is an author at Inserm specializing in medicine, osteoporosis, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	65	4K
2	Health Sciences	17	23	1.5K
3	Engineering	4	4	195
4	Natural Sciences	1	1	15
5	Public Health	1	1	10

M.C. de Vernejoul

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study Jean‐Yves Reginster, Ego Seeman, M.C. de Vernejoul, The Journal of Clinical Endocrinology & Metabolism	2005	1.1K
Quality of Life in Patients with Vertebral Fractures: Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) Paul Lips, Cyrus Cooper, D. Agnusdei, Osteoporosis International Bone DiseaseQuality Of LifeLife AssessmentSkeletal TraumaFracture Diagnostics	1999	404
Strontium Ranelate: Dose-Dependent Effects in Established Postmenopausal Vertebral Osteoporosis—A 2-Year Randomized Placebo Controlled Trial P. J. Meunier, Daniel O. Slosman, Pierre D. Delmas, The Journal of Clinical Endocrinology & Metabolism	2002	317
Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. Pablo Ureña, M Hrubý, Aníbal Ferreira, Journal of the American Society of Nephrology Dialysis TherapyHemodialysis PatientsPlasma BapOsteoporosisOrthopaedic Surgery	1996	256
Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients Olivier Bénichou, Jean‐Denis Laredo, M.C. de Vernejoul Bone Systemic SclerodermaRadiological ManifestationsAlbers-schönberg DiseaseDermatologyScleroderma	2000	236
Optimal correction of acidosis changes progression of dialysis osteodystrophy Alfred Lefebvre, M.C. de Vernejoul, J Guéris, Kidney International HemodialysisUrologyMedicineKidney FailureDialysis Therapy	1989	197
Evidence for Defective Osteoblastic Function A Role for Alcohol and Tobacco Consumption in Osteoporosis in Middle-aged Men M.C. de Vernejoul, J. Bielakoff, M A Herve, Clinical Orthopaedics and Related Research Bone DiseaseUrologyBody CompositionBone HealthOrthopaedic Surgery	1983	189
Quality of life as outcome in the treatment of osteoporosis: The development of a questionnaire for quality of life by the European foundation for osteoporosis Paul Lips, Cyrus Cooper, D. Agnusdei, Osteoporosis International Bone DiseaseQuality Of LifeLife SatisfactionLife AssessmentSocial Health	1997	143
Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. Martine Cohen‐Solal, A.M. Graulet, M.A. Denne, The Journal of Clinical Endocrinology & Metabolism InflammationBone DiseaseTnf Alpha LevelsBone ResorptionOrthopaedic Surgery	1993	128
The serotonin 5‐HT <sub>2B</sub> receptor controls bone mass <i>via</i> osteoblast recruitment and proliferation Corinne Collet, Corinne Schiltz, Valérie Geoffroy, The FASEB Journal	2007	114

Page 1